Thus, since Emerin deregulation is associated with increased metastatic potential15,40,41 but no frequent mutations or significant changes in gene expression were found in cancer patients, alternative the presence of Emerin at the NE might be modulated through other mechanisms, e.g., through its aberrant localization15. The gene discussed is EMD; the disease is cancer.